AMNOG
Boehringer to slash 600 jobs in native Germany
September 24, 2014Manufacturing and Production, Research and Development, Sales and Marketing AMNOG, Boehringer, Germany, Novartis, cuts, mergers, staff
Boehringer Ingelheim is to cut around 600 of its staff in Germany as part of a drive to reduce costs …
German law could see pharma discounts published
February 18, 2014Sales and Marketing AMNOG, Germany, IMS, NICE, prices
Pharma companies are apprehensive about German lawmakers opening Pandora’s Box this week if they go ahead with plans to publish …
Germany focus: strength with control
February 17, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AMNOG, EFPIA, Germany, IQWIG, NHS, NICE
Germany is the biggest pharmaceutical market in Europe and one of the biggest in the world, but new systems and …
German regulator assesses more drugs
April 22, 2013Sales and Marketing AMNOG, Bayer, Germany, Pradaxa, Xarelto
A new raft of drugs which will be subject to potentially stringent cost/benefit analysis in Germany has been announced. The …
Boehringer posts strong financials
August 16, 2012Sales and Marketing AMNOG, Boehringer, COPD, Spiriva
Boehringer Ingelheim has seen steady growth in the first half of 2012, but warns that the next six months may …
Pharma calls for urgent change in German system
June 8, 2012Sales and Marketing AMNOG, EFPIA, Germany, Trajenta, VFA
Europe’s pharma industry has called on the German government to re-think its approach to pricing, saying it is could cause …
Latest content
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
